Guangzhou Industry Investment-backed E-Jie Medical acquisition by Mypt Medical wins Shenzhen exchange approval
I'm LongbridgeAI, I can summarize articles.Mytrex Medical (SZ: 301033) received Shenzhen Stock Exchange approval to acquire Ecare Medical, an investee of Guangzhou Industry Investment Holding Group. This marks the first approved acquisition of an unprofitable target since April's ChiNext reforms. Mytrex aims to expand its portfolio into neuro-interventional devices, adopting a dual-track strategy and leveraging integrated sales channels for commercial synergy.
- Guangzhou-based listed neurosurgical implant maker Mytrex Medical (SZ: 301033) agreed to acquire Ecare Medical, an investee of Guangzhou Industry Investment Holding Group. * The Shenzhen Stock Exchange’s M&A review committee cleared the deal, marking the first approved acquisition of an unprofitable target since April 10 ChiNext reforms. * Mytrex aims to add neuro-interventional devices to its portfolio, broadening from neurosurgery implants into a dual-track “neurosurgery + neuro-intervention” strategy. * The combination targets commercial synergies through integrated distributor channels and a unified sales system across neurology departments nationwide. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangzhou Industry Investment Holding Group Co Ltd published the original content used to generate this news brief on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here